- Pedestrian killed during traffic collision on I-55 (10/23/16)7
- Scott County Sheriff Rick Walter faces challenge from criminal investigator Wes Drury (10/21/16)8
- Shooting injures two people in Cape early Tuesday (10/19/16)34
- 18-year-old killed in one-car crash Thursday morning (10/21/16)1
- Man arrested after dispute at school spurs brief lockdown (10/21/16)6
- 'I feel for them' (10/20/16)1
- Perry County: A great place to find home away from home (10/14/16)
- Tours provide a glimpse of Cape Girardeau's supposedly haunted past (10/17/16)1
- Crews are working on the new Drury Hotel (10/21/16)4
- Benton man accused of statutory rape, selling pot (10/20/16)1
FDA requires new labels on HRT products
WASHINGTON -- The government announced new warnings Wednesday on the labels for hormone replacement therapies and advised millions of post-menopausal women to consult their doctors about whether to continue treatment.
The Food and Drug Administration acted after reviewing data from a landmark study that found that the increased risk of heart disease and breast cancer from using therapies combining the hormones estrogen and progestin far outweighed any health benefits. The government abruptly halted that study last July.
The FDA approved new labels for Wyeth Pharmaceuticals that includes a new boxed warning highlighting the increased risk for heart disease, heart attacks, strokes and breast cancer. They also include a reference to the study findings.
The new labels also emphasize that these products are not approved for the prevention of heart disease.
The FDA also said it was asking all manufacturers of estrogen and estrogen-progestin products to add similar warnings and change the enclosed patient information leaflet because all hormone products are believed to carry similar health risks.